Capital structure
InspireMD resets Series J/K warrant terms ahead of CGuard Prime FDA catalyst
Participating holders take a $0.7674 exercise price and an earlier termination window tied to CGuard Prime 80 cm approval; half of amended Series J warrants stay at $1.3827.
